• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过顺铂微囊化和局部注射增强犬肾中铂的摄取。

Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection.

作者信息

Hecquet B, Depadt G, Fournier C, Meynadier J

出版信息

Anticancer Res. 1986 Jan-Feb;6(1):65-9.

PMID:3954334
Abstract

Microcapsules containing cisplatin were administered into the renal artery of mongrel dogs. Significant increase of the platinum tissue concentration in the kidney was observed 17 days after administration compared to injection of cisplatin only. The highest drug tissue levels were obtained when the renal artery was ligated after microcapsule injection. In addition the decrease in plasma levels indicated that microencapsulation causes, at least, a 100-fold enhancement of the ratio: exposure of infused tissue to the drug over total body exposure. On the contrary, no major change in drug urine excretion could be related to microencapsulation.

摘要

将含顺铂的微胶囊注入杂种犬的肾动脉。与仅注射顺铂相比,给药17天后观察到肾脏中铂组织浓度显著增加。微胶囊注射后结扎肾动脉时可获得最高的药物组织水平。此外,血浆水平的降低表明微囊化至少使以下比率提高了100倍:注入组织对药物的暴露量与全身暴露量之比。相反,药物尿排泄的主要变化与微囊化无关。

相似文献

1
Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection.通过顺铂微囊化和局部注射增强犬肾中铂的摄取。
Anticancer Res. 1986 Jan-Feb;6(1):65-9.
2
[Serum concentration and distribution in the liver, lung, heart and kidney of platinum after hepatic arterial injection in the form of cis-diammine dichloroplatinum microcapsule in rabbits].[顺二氯二氨铂微胶囊经肝动脉注射后兔体内铂的血清浓度及在肝、肺、心、肾中的分布]
Zhonghua Wai Ke Za Zhi. 1990 Nov;28(11):686-8, 704.
3
Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.给狗静脉注射顺二氯二氨铂(II)(NSC 119875)后铂的分布与处置情况。
Cancer Res. 1976 Jul;36(7 PT 1):2340-4.
4
[Studies on adequate intervals of cisplatin administration to ameliorate cisplatin-induced nephrotoxicity].[关于顺铂给药适宜间隔以减轻顺铂诱导的肾毒性的研究]
Gan To Kagaku Ryoho. 1986 Feb;13(2):239-46.
5
Mechanism of cisplatin nephrotoxicity.顺铂肾毒性的机制。
Fed Proc. 1983 Oct;42(13):2974-8.
6
[Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report].[组织铂分布及肝动脉注射顺铂对转移性肝癌的疗效——1例报告]
Gan To Kagaku Ryoho. 2001 Aug;28(8):1149-53.
7
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
8
Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.给动物肠胃外注射顺式二氯二氨铂(II)后铂的处置与分布。
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1485-92.
9
Increase in serum uric acid level associated with cisplatin therapy. Correlation with liver but not kidney platinum concentrations.顺铂治疗相关的血清尿酸水平升高。与肝脏而非肾脏铂浓度的相关性。
Arch Intern Med. 1985 Nov;145(11):2013-4.
10
Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice.
Anticancer Res. 1994 Jan-Feb;14(1A):113-8.